About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Amh-SMAD2*)#Jebu
transgene insertion, Joanna E Burdette
MGI:5543909
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Tg(Amh-SMAD2*)#Jebu/0
Trp53tm1Brn/Trp53tm1Brn
involves: 129P2/OlaHsd * FVB/N MGI:5543911
tg2
Tg(Amh-SMAD2*)#Jebu/0 FVB/N-Tg(Amh-SMAD2*)#Jebu MGI:5543910


Genotype
MGI:5543911
cn1
Allelic
Composition
Tg(Amh-SMAD2*)#Jebu/0
Trp53tm1Brn/Trp53tm1Brn
Genetic
Background
involves: 129P2/OlaHsd * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Amh-SMAD2*)#Jebu mutation (0 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• 1 of 7 mice injected with an adenovirus expressing cre recombinase into the bursa develop fluid-filled bursal cysts 6 months after injection
• however, mice injected with an adenovirus expressing cre recombinase into the oviduct exhibit no change in phenotype 3 or 6 months after injection
• 2 of 6 mice injected with an adenovirus expressing cre recombinase into the bursa develop teratoma 3 months after injection

reproductive system
• 1 of 7 mice injected with an adenovirus expressing cre recombinase into the bursa develop fluid-filled bursal cysts 6 months after injection
• however, mice injected with an adenovirus expressing cre recombinase into the oviduct exhibit no change in phenotype 3 or 6 months after injection
• 2 of 6 mice injected with an adenovirus expressing cre recombinase into the bursa develop teratoma 3 months after injection

neoplasm
• 2 of 6 mice injected with an adenovirus expressing cre recombinase into the bursa develop teratoma 3 months after injection

growth/size/body
• 1 of 7 mice injected with an adenovirus expressing cre recombinase into the bursa develop fluid-filled bursal cysts 6 months after injection
• however, mice injected with an adenovirus expressing cre recombinase into the oviduct exhibit no change in phenotype 3 or 6 months after injection




Genotype
MGI:5543910
tg2
Allelic
Composition
Tg(Amh-SMAD2*)#Jebu/0
Genetic
Background
FVB/N-Tg(Amh-SMAD2*)#Jebu
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• mutants develop ovarian inclusion cysts; mice that only develop inclusion cysts show low transgene expression
• 3 of 18 mutants exhibit abnormal tumor-like ovaries at 8 weeks of age, with tumors showing some, but not all the characteristics of the mature teratomas
• 5 of 18 mutants develop ovarian teratomas at 2-6 months of age, some of which appear malignant; mice that develop teratomas show high transgene expression
• teratomas are characterized by areas of invasive, undifferentiated cells and inclusion cysts lined with ciliated cells reminiscent of oviductal or respiratory epithelium
• 3 of the tumors contain squamous cell-lined cysts filled with keratin and well-to-moderately differentiated invasive squamous cells and nervous tissue-like areas
• fat, blood-filled spaces, calcified bone and cartilage formation, and thyroid gland-like structures are seen in some teratomas
• by 6 months of age, teratomas are about 10 times the size of a normal ovary, do not show normal follicular or ovarian structures, and contain many highly proliferative epithelium-lined inclusion cysts

reproductive system
• mutants develop ovarian inclusion cysts; mice that only develop inclusion cysts show low transgene expression
• 3 of 18 mutants exhibit abnormal tumor-like ovaries at 8 weeks of age, with tumors showing some, but not all the characteristics of the mature teratomas
• 5 of 18 mutants develop ovarian teratomas at 2-6 months of age, some of which appear malignant; mice that develop teratomas show high transgene expression
• teratomas are characterized by areas of invasive, undifferentiated cells and inclusion cysts lined with ciliated cells reminiscent of oviductal or respiratory epithelium
• 3 of the tumors contain squamous cell-lined cysts filled with keratin and well-to-moderately differentiated invasive squamous cells and nervous tissue-like areas
• fat, blood-filled spaces, calcified bone and cartilage formation, and thyroid gland-like structures are seen in some teratomas
• by 6 months of age, teratomas are about 10 times the size of a normal ovary, do not show normal follicular or ovarian structures, and contain many highly proliferative epithelium-lined inclusion cysts

neoplasm
• 3 of 18 mutants exhibit abnormal tumor-like ovaries at 8 weeks of age, with tumors showing some, but not all the characteristics of the mature teratomas
• 5 of 18 mutants develop ovarian teratomas at 2-6 months of age, some of which appear malignant; mice that develop teratomas show high transgene expression
• teratomas are characterized by areas of invasive, undifferentiated cells and inclusion cysts lined with ciliated cells reminiscent of oviductal or respiratory epithelium
• 3 of the tumors contain squamous cell-lined cysts filled with keratin and well-to-moderately differentiated invasive squamous cells and nervous tissue-like areas
• fat, blood-filled spaces, calcified bone and cartilage formation, and thyroid gland-like structures are seen in some teratomas
• by 6 months of age, teratomas are about 10 times the size of a normal ovary, do not show normal follicular or ovarian structures, and contain many highly proliferative epithelium-lined inclusion cysts

growth/size/body
• mutants develop ovarian inclusion cysts; mice that only develop inclusion cysts show low transgene expression

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dermoid cyst of ovary DOID:5117 OMIM:166950
J:200783





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory